tick borne encephalitis vaccine (Pending FDA Approval)

Brand and Other Names:TicoVac, TBE vaccine (whole virus inactivated)
  • Print
Sections

Dosing & Uses

AdultPediatric

Tick-Borne Encephalitis

Pending FDA approval for active immunization to prevent tick-borne encephalitis

Tick-Borne Encephalitis

Pending FDA approval for active immunization to prevent tick-borne encephalitis in individuals aged ≥1 year

Next:

Pharmacology

Mechanism of Action

Inactivated whole virus vaccine developed using a master ‘seed’ virus that is similar to the TBE virus found in nature; therefore, it is able to induce neutralizing antibodies against the natural TBE virus

Provides protection against all known subtypes of TBE virus, including European, Siberian, and Far Eastern subtypes

Previous
Next:

Images

No images available for this drug.
Previous
Next:

Patient Handout

A Patient Handout is not currently available for this monograph.
Previous
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.